Written answers
Tuesday, 5 July 2016
Department of Health
Drugs Payment Scheme Coverage
Peter Burke (Longford-Westmeath, Fine Gael)
Link to this: Individually | In context | Oireachtas source
515. To ask the Minister for Health if he will fund the drug Ampligen for suffers of myalgic encephalomyelitis; and if he will make a statement on the matter. [19325/16]
Simon Harris (Wicklow, Fine Gael)
Link to this: Individually | In context | Oireachtas source
The HSE has statutory responsibility for decisions on pricing and reimbursement of medicinal products under the community drug schemes, in accordance with the Health (Pricing and Supply of Medical Goods) Act 2013. Prior to reimbursing any item, the HSE considers a range of statutory criteria, including clinical need, cost-effectiveness and the resources available.
The holder of a market authorisation for a product may apply to the HSE to have the product reimbursed in Ireland. The HSE has advised that it does not currently have an application for reimbursement of the drug in question.
No comments